Eleven participants had defined mutations in COL3A1, three were diagnosed with an EDS specific skin biopsy by electron microscopic examination and eight were diagnosed by clinical evaluation of a geneticist (Table 1). The gene discussed is COL3A1; the disease is Ehlers-Danlos syndrome.